We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Edwards Lifesciences (EW) Looks Good: Stock Adds 6.2% in Session
Read MoreHide Full Article
Edwards Lifesciences Corporation (EW - Free Report) was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $168.13 to $179.75 in the past one-month time frame.
The move came after the company reported positive results from its aortic valve surgical treatment trial.
The company has seen a mixed track record when it comes to estimate revision of one increase and no decrease over the past few weeks, while the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Edwards Lifesciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Is EW going up? Or down? Predict to see what others think:Up or Down
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?
Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.
Image: Bigstock
Edwards Lifesciences (EW) Looks Good: Stock Adds 6.2% in Session
Edwards Lifesciences Corporation (EW - Free Report) was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $168.13 to $179.75 in the past one-month time frame.
The move came after the company reported positive results from its aortic valve surgical treatment trial.
The company has seen a mixed track record when it comes to estimate revision of one increase and no decrease over the past few weeks, while the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Edwards Lifesciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Edwards Lifesciences Corporation Price
Edwards Lifesciences Corporation Price | Edwards Lifesciences Corporation Quote
Investors interested in the Medical - Instruments industry may consider a better-ranked stock like Integer Holdings Corporation (ITGR - Free Report) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is EW going up? Or down? Predict to see what others think:Up or Down
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?
Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.
See Latest Stocks Today >>